Endocrine Abstracts

Contents

• 21th European Congress of Endocrinology 2019
• • Prize Lectures and Biographical Notes
  • The European Journal of Endocrinology Prize Lecture
  • • New approaches in the differential diagnosis of Diabetes insipidus

      ea0063eje1
    • EJE Award 2019 - Biography

      ea0063eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Translational research in pituitary disease

      ea0063gh1
    • ESE Geoffrey Harris Prize 2019 - Biography

      ea0063gh1biog
  • European Hormone Medal Lecture
  • • Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis

      ea0063ehm1
    • European Hormone Medal 2019 - Biography

      ea0063ehm1biog
  • Clinical Endocrinology Trust Lecture
  • • How can patients' perception of outcome be improved after controlling pituitary disease?

      ea0063cet1
    • Clinical Endocrinology Trust Award 2019 - Biography

      ea0063cet1biog
• Plenary Lectures
• • Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
  • • Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease

      ea0063pl1
  • Genetic epidemiology of puberty timing and reproductive lifespan (Endorsed by the European Journal of Endocrinology)
  • • Genetic epidemiology of puberty timing and reproductive lifespan

      ea0063pl2
  • Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
  • • Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes

      ea0063pl3
  • Exercise Training in the Management of Type 2 Diabetes
  • • Exercise Training in the Management of Type 2 Diabetes

      ea0063pl4
  • Paracrine regulation of the adrenal cortex
  • • Paracrine regulation of the adrenal cortex

      ea0063pl5
  • Graves orbitopathy
  • • Graves Orbitopathy

      ea0063pl6
  • Control of Integrative Physiology by the Melanocortin Circuitry
  • • Control of Integrative Physiology by the Melanocortin Circuitry

      ea0063pl7
• Symposia
• • Thyroid in cancer
  • • What is the value of molecular markers in nodules?

      ea0063s1.1
    • Iodine refractoriness in thyroid cells

      ea0063s1.2
    • New paradigms in the treatment of low risk thyroid cancer

      ea0063s1.3
  • Trends in puberty
  • • Exploring the Epigenetic landscape of puberty

      ea0063s2.1
    • Endocrine disrupters in puberty

      ea0063s2.2
    • The genetic basis of pubertal timing

      ea0063s2.3
  • Circadian clocks: from pathophysiology to chronomedicine
  • • Circadian control of glucocorticoid function

      ea0063s3.1
    • Fixing the broken clock in adrenal disorders

      ea0063s3.2
    • Understanding the molecular basis of seasonal changes in behavior

      ea0063s3.3
  • Immunology and endocrinology (Endorsed by Endocrine Connections)
  • • Basic: immunotherapy and endocrine disease

      ea0063s4.1
    • Clinical: Immunotherapy and endocrine disease

      ea0063s4.2
    • Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders

      ea0063s4.3
  • Microbiota as new treatment for diabetes and metabolic disease
  • • Human gut microbiome: hopes, threats and promises

      ea0063s5.1
    • Fecal transplantation: Myth or reality

      ea0063s5.2
    • Targeted Microbiome Intervention for handling insulin resistance

      ea0063s5.3
  • A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology)
  • • Prediction of the thyroid axis set-point

      ea0063s6.1
    • Subclinical hypothyroidism in children

      ea0063s6.2
    • Subclinical hypothyroidism in the elderly

      ea0063s6.3
  • Endocrine disrupting chemicals (Endorsed by Endocrine Connections)
  • • Mixtures measured in human, disrupt thyroid hormone signaling and behavior in Xenopus laevis

      ea0063s7.1
    • Actions of endocrine disrupting chemicals on pancreatic beta cells and risk of diabetes mellitus

      ea0063s7.2
    • Prenatal obesogen exposure leads to a transgenerational thrifty phenotype in mice

      ea0063s7.3
  • Genderdysphoria - delayed puberty
  • • Psychoendocrinology of gender dysphoria

      ea0063s8.1
    • Management of puberty in transgender adolescents

      ea0063s8.2
    • Gender reassignment surgery in dysphoria

      ea0063s8.3
  • Controversies in adrenal disease
  • • Metanephrines: Plasma or Urine

      ea0063s9.1
    • The dos and don'ts of genetic testing in phaeochromocytoma

      ea0063s9.2
    • Is there a role for subtotal adrenalectomy

      ea0063s9.3
  • Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections)
  • • Mechanisms of skeletal metastasis

      ea0063s10.1
    • Aromatase inhibitors and bone

      ea0063s10.2
    • TSH suppressive therapy and bone

      ea0063s10.3
  • EDCs & reproduction
  • • Impact of pesticide postnatal exposure on oocyte quality and clinical outcomes of patient undergoing IVf programme

      ea0063s11.1
    • Environmental endocrine disruptors and testicular germ cell cancer

      ea0063s11.2
    • Mitigating against endocrine disruption in pregnancy

      ea0063s11.3
  • Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
  • • The view of the surgeon: When, how much and when to refrain from surgery?

      ea0063s12.1
    • New potential treatment alternatives in patients with papillary craniopharyngioma

      ea0063s12.2
    • How to manage the long-term consequences of hypothalamic damages

      ea0063s12.3
  • Central control of metabolism: Brain rules all
  • • Sensors of survival: Pleiotropic function and the regulation of hunger circuits

      ea0063s13.1
    • Role of mitochondria/cell bioenergetics in CNS regulation of energy balance

      ea0063s13.2
    • Genetics of appetite regulation: Can an old dog teach us new tricks?

      ea0063s13.3
  • Innovations in NETs
  • • Innovative imaging of benign insulinomas - the end of sampling

      ea0063s14.1
    • A role for radionuclide therapy for high-grade NETs

      ea0063s14.2
    • Fishing for NETs

      ea0063s14.3
  • European Young Endocrine Scientists (EYES)
  • • European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease

      ea0063s15.1
    • Investigating glucocorticoid excess as mediators of bone marrow adiposity expansion during caloric restriction

      ea0063s15.2
    • Best young abstract submission

      ea0063s15.3
    • The role and cross-talk between incretin hormones and occurrence of non-alcoholic steatohepatitis

      ea0063s15.4
    • Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome

      ea0063s15.5
    • Closing remarks and invitation to the EYES social

      ea0063s15.6
  • Thyroid in pregnancy
  • • Thyroid autoimmunity and (in)fertility

      ea0063s16.1
    • Thyroid disease and pregnancy outcomes

      ea0063s16.2
    • Mild maternal thyroid dysfunction during pregnancy and offspring neurodevelopment

      ea0063s16.3
  • Where do pituitary tumours come from?
  • • Specification of pituitary cell fates

      ea0063s17.1
    • Pertubations in novel signalling pathways

      ea0063s17.2
    • 'From Lab to Clinic - Can we translate into effective therapeutics'

      ea0063s17.3
  • Congenital hypogonadotropic hypogonadism: New insights into GnRH Regulation
  • • The transcription factor Gli3 plays a pivotal role in controlling the development of the terminal nerve and GnRH-1 neuronal migration

      ea0063s18.1
    • Flipping the GnRH switch with microRNAs

      ea0063s18.2
    • Congenital hypogonadotropic hypogonadism: clinical perspectives

      ea0063s18.3
  • Adrenal insufficiency
  • • New insights into autoimmune adrenal insuffisiency

      ea0063s19.1
    • Long-term results of modified release glucocorticoids in adrenal insufficiency - are they really better?

      ea0063s19.2
    • Optimising care delivery in congenital adrenal hyperplasia

      ea0063s19.3
  • News on nutrition: when to eat what
  • • Precision nutrition for managing obesity - does it work?

      ea0063s20.1
    • Is limiting the timing of food intake a viable nutritional approach?

      ea0063s20.2
    • PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health

      ea0063s20.3
  • Rare bone disorders
  • • Animal models of bone fragility

      ea0063s21.1
    • New perspectives on the treatment of skeletal dysplasia

      ea0063s21.2
    • Osteogenesis imperfecta throughout life

      ea0063s21.3
  • The pituitary as metabolic sensor (Endorsed by Endocrine Connections)
  • • Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis

      ea0063s22.1
    • How treatments with endocrine & metabolic drugs influence pituitary cell function?

      ea0063s22.2
    • Bidirectional interrelationship between growth hormone and metabolism

      ea0063s22.3
  • PCOS: can we personalise treatment?
  • • Gut and brain axis

      ea0063s23.1
    • Implicating androgen excess in metabolic disease in PCOS

      ea0063s23.2
    • Treatment options in cardiometabolic pcos phenotype

      ea0063s23.3
  • What's new in the Adrenal Cortex? (Endorsed by the European Journal of Endocrinology)
  • • Adrenocortical tumors: new genes, new understanding, new therapy

      ea0063s24.1
    • Primary hyperaldosteronism: does our treatment work?

      ea0063s24.2
    • Autonomous cortisol secretion has cardiovascular consequences

      ea0063s24.3
  • Late Breaking Session
  • • Liver Stress kinases - crossroad between obesity and liver cancer (Source paper: Nature 2019)

      ea0063s25.1
    • Levothyroxine in preconception women with thyroid peroxidase antibodies

      ea0063s25.2
    • Maternal smoking and high BMI disrupt thyroid gland development

      ea0063s25.3
  • Impact of thyroid disease on...
  • • Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders

      ea0063s26.1
    • Bone

      ea0063s26.2
    • Thyroid hormones in the cardiac physiopathology

      ea0063s26.3
  • What's new in reproductive endocrinology?
  • • Dissecting androgens in Polycystic Ovary Syndrome (PCOS)

      ea0063s27.1
    • Large scale genetic studies in male infertility

      ea0063s27.2
    • Menopause and cardiovascular risk

      ea0063s27.3
  • Vitamin D - non-skeletal effects in RCT
  • • Vitamin D for healthy ageing

      ea0063s28.1
    • Vitamin D and type 1 diabetes

      ea0063s28.2
    • How and when to measure vitamin D?

      ea0063s28.3
  • Endocrine controversies in sport
  • • Female hyperandrogenism and elite sport

      ea0063s29.1
    • Performance enhancing drugs in young males

      ea0063s29.2
    • Omics to fight doping

      ea0063s29.3
  • Personalised medicine in diabetes and obesity (Endorsed by the European Journal of Endocrinology)
  • • Mechanisms for Cardiovascular Complications of Diabetes - Implications for Personalized Therapy

      ea0063s30.1
    • New avenues for novel drugs to treat obesity

      ea0063s30.2
    • Curing diabetes with alternatives: bariatric surgery

      ea0063s30.3
  • Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - Endocrinology of Aging
  • • Obesity gives you cancer: the bigger picture!

      ea0063ss1.1
    • Sleep deficiency: A pathway to obesity

      ea0063ss1.2
    • Obesity is an economic burden and we know why

      ea0063ss1.3
• New Scientific Approaches
• • (1)
  • • Steroidomics

      ea0063nsa1
    • Single cell spatial reconstruction of endocrine organs

      ea0063nsa2
    • Intelligent image based in situ single cell isolation

      ea0063nsa3
    • How can AI create value for the endocrinologist? Challenges and opportunities for AI-enabled solutions

      ea0063nsa4
    • Genome-wide effects of vitamin D on chromatin

      ea0063nsa5
    • Diving into the brain: deep brain imaging techniques in conscious animals.

      ea0063nsa6
• Debates
• • Food addiction in humans: to be or not to be?
  • • PRO: Food addiction in humans: to be or not to be?

      ea0063d1.1
    • CON: Food addiction in humans: to be or not to be?

      ea0063d1.2
  • Surgical treatment of phaeochromocytoma - query pre-treatment
  • • PRO: Surgical treatment of phaeochromocytoma - query pre-treatment?

      ea0063d2.1
    • CON: Surgical treatment of phaeochromocytoma - query pre-treatment?

      ea0063d2.2
  • T4 is not enough
  • • 'Yes, T4 is not enough'

      ea0063d3.1
    • 'No, T4 is enough'

      ea0063d3.2
  • Pituitary pathology: Do we care?
  • • Yes, we care about pituitary pathology!

      ea0063d4.1
    • No, we don't care about pituitary pathology

      ea0063d4.2
  • MicroRNAs as hormones?
  • • PRO: MicroRNAs and extracellular vesicles as hormones?

      ea0063d5.1
    • CON: MicroRNAs and extracellular vesicles as hormones?

      ea0063d5.2
  • Should we treat young osteoporotic patients?
  • • Yes, we should treat young osteoporotic patients

      ea0063d6.1
    • 'No, we shouldn't treat young osteoporotic patients'

      ea0063d6.2
• Meet the Expert Sessions
• • (1)
  • • The road from flash glucose monitoring to hybrid closed loop systems: keys to success.

      ea0063mte1
    • Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?

      ea0063mte2
    • The management of primary aldosteronism

      ea0063mte3
    • Management of a life-long disease in CAH

      ea0063mte4
    • Risk classification of thyroid nodules by ultrasound and indications for FNA

      ea0063mte5
    • Primary Hyperparathyroidism: Surgical vs. Medical Therapy

      ea0063mte6
    • Non functional Pituitary Tumours - not always easy

      ea0063mte7
    • Comorbidities in Turner Syndrome

      ea0063mte8
    • Co-morbidities in Klinefelter syndrome

      ea0063mte9
    • NCAH and Female Reproduction

      ea0063mte10
    • 'Shifting treatment paradigms in osteoporosis'.

      ea0063mte11
    • Fracture Risk Prediction in Benign and Tumoral Bone: New Insights

      ea0063mte12
    • Flushing, blushing and sweating

      ea0063mte13
    • How multidisciplinay care and tailor-made transition save lives of young adults with Prader-Willi syndrome

      ea0063mte14
    • To what degree does hypopituitarism exist after TBI?

      ea0063mte15
    • Is it all in your head or just in the lab?

      ea0063mte16
    • The metabolic effects of SGLT2 inhibitors - Does the increase in ketone bodies protect the heart?

      ea0063eyijc1
• Meet the Basic Scientist Session
• • (1)
  • • New tracers for PET in humans: Hopes, aims and current evidence

      ea0063mtbs1
    • Genetically tailored pig models in translational endocrine and metabolic research

      ea0063mtbs2
    • The gravitostat - possible relation to hormones

      ea0063mtbs3
• Nurse Sessions
• • (1)
  • • Overview of immunotherapy: Indications and adverse effects

      ea0063ns1.1
    • Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring

      ea0063ns1.2
    • The role of the endocrine nurse in managing patients with immunotherapy-induced endocrinopathies

      ea0063ns1.3
    • Nursing approach to the holistic care of patients with intellectual disability

      ea0063mtne1
    • Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards

      ea0063npd1
    • Testosterone replacement: 'The best practice'.

      ea0063npd2
    • Hypoparathyroidism: Aetiology, diagnosis and challenges in management

      ea0063npd2.1
    • How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)

      ea0063npd3
    • MY DIABBY - Improving skills and competence in diabetes education

      ea0063npd4
    • How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)

      ea0063npd5
• Uems Session
• • (1)
  • • The role of UEMS in Europe and the distinct and independent but allied pathway with ESE

      ea0063uems1.1
    • Update on European Exam in Endocrinology

      ea0063uems1.2
    • The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells

      ea0063uems1.3
• Oral Communications
• • Calcium and Bone
  • • Genetic testing for hereditary hyperparathyroidism in a large UK cohort

      ea0063oc1.1
    • Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism

      ea0063oc1.2
    • Menin and EZH2 activities modulate the expression of the long non-coding RNA HAR1B in parathyroid tumors

      ea0063oc1.3
    • Risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063oc1.4
    • Renal function in 711 patients with hypoparathyroidism during more than 4 years of therapy

      ea0063oc1.5
  • Diabetes 1
  • • Every fifth patient with type 1 diabetes suffers from an additional endocrinological autoimmune disease - a finnish nationwide study

      ea0063oc2.1
    • Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission

      ea0063oc2.2
    • Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes

      ea0063oc2.3
    • Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice

      ea0063oc2.4
    • 5[beta]-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo

      ea0063oc2.5
  • Cushing's and acromegaly
  • • Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study

      ea0063oc3.1
    • Outcomes after primary treatment for Nelson's syndrome: a study from 13 UK centres

      ea0063oc3.2
    • Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale

      ea0063oc3.3
    • Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial

      ea0063oc3.4
    • T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly

      ea0063oc3.5
  • Thyroid 1
  • • Subclinical hypothyroidism troughout pregnancy in TPOAb positive pregnant women

      ea0063oc4.1
    • Thyroid dysfunction and mortality in cardiovascular hospitalized patients - a 12 year follow-up observational study

      ea0063oc4.2
    • Prognostic impact of microscopic extrathyroidal extension (mETE) on recurrence-free survival in patients with papillary thyroid carcinoma (PTC)

      ea0063oc4.3
    • Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France

      ea0063oc4.4
    • A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project

      ea0063oc4.5
  • Adrenal 1
  • • Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma

      ea0063oc5.1
    • Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved

      ea0063oc5.2
    • SF3B1 as novel target for the treatment of multiple endocrine-related cancers

      ea0063oc5.3
    • The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy

      ea0063oc5.4
    • Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients

      ea0063oc5.5
  • Obesity
  • • Impaired glucose homeostasis in leptin-deficient ob/ob mice is corrected by AZP-3404, a 9-amino acid peptide analog derived from insulin-like growth factor-binding protein 2, a key mediator of leptin action

      ea0063oc6.1
    • Deep Transcranial Magnetic Stimulation modulates body temperature in obesity

      ea0063oc6.2
    • Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance

      ea0063oc6.3
    • Fat mass impact of sirolimus after clinical islet transplantation, a case control study

      ea0063oc6.4
    • Lipolysis defect in white adipose tissue and rapid weight regaining

      ea0063oc6.5
  • Endocrine Connections 1
  • • Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women

      ea0063oc7.1
    • Thyroid hormones are new key regulators of glucocorticoid metabolism

      ea0063oc7.2
    • Higher dose of burosumab is needed for treatment of children with sever forms of X-linked hypophosphatemia

      ea0063oc7.3
    • Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA

      ea0063oc7.4
    • Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome: French prospective study in a cohort of 25 patients

      ea0063oc7.5
  • Reproduction 1
  • • Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse

      ea0063oc8.1
    • AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients

      ea0063oc8.2
    • Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus

      ea0063oc8.3
    • Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH neurons reveals specific roles in reproductive and metabolic homeostasis

      ea0063oc8.4
    • The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: responder analysis results from a randomized, placebo-controlled, double-blind, dose-ranging study

      ea0063oc8.5
  • Thyroid 2
  • • 3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism

      ea0063oc9.1
    • Direct evidence for disulfides in the mechanism of deiodinase 1

      ea0063oc9.2
    • Novel driver mutations in thyroid cancer recurrence

      ea0063oc9.3
    • Resistance to thyroid hormone alpha associated with early-onset severe NASH

      ea0063oc9.4
    • Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models

      ea0063oc9.5
  • Adrenal 2
  • • Steroid metabolomics: a rapid computational approach for accurate differentiation of inborn disorders of steroidogenesis

      ea0063oc10.1
    • Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism

      ea0063oc10.2
    • Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients

      ea0063oc10.3
    • Cullin 3 is a partner of armadillo repeat containing 5 (ARMC5), the product of the gene responsible for primary bilateral macronodular adrenal hyperplasia

      ea0063oc10.4
    • Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma

      ea0063oc10.5
  • Diabetes 2
  • • Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study

      ea0063oc11.1
    • Molecular mechanisms regulating hepatic sex hormone-binding globulin production: clinical implications in human diseases

      ea0063oc11.2
    • Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes

      ea0063oc11.3
    • MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease

      ea0063oc11.4
    • Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study

      ea0063oc11.5
  • Endocrine Connections 2
  • • Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover

      ea0063oc12.1
    • Epigenetic programming of transgenerational hypertension in preterm birth mice

      ea0063oc12.2
    • Neuronostatin and GPR107 system: a novel therapeutic circuit in prostate cancer

      ea0063oc12.3
    • Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France

      ea0063oc12.4
    • Sexual desire in transgender persons in relation with gender affirming hormone treatment: Results from ENIGI, a large multicenter prospective cohort study in transgender people

      ea0063oc12.5
  • Anterior and Posterior pituitary 2
  • • Arginine-stimulated copeptin measurements - a new test for diabetes insipidus

      ea0063oc13.1
    • Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion - a randomized, double-blind, placebo-controlled trial

      ea0063oc13.2
    • Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype

      ea0063oc13.3
    • Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study

      ea0063oc13.4
    • Pan-genomic classification of pituitary adenomas

      ea0063oc13.5
  • Sex Hormones
  • • Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial

      ea0063oc14.1
    • The effect of testosterone therapy on serum oestradiol levels in transgender men

      ea0063oc14.2
    • First identification of bone morphogenic protein receptor variants as a cause of primary ovarian insufficiency

      ea0063oc14.3
    • Thyroid diseases in danish women with polycystic ovary syndrome

      ea0063oc14.4
    • The pattern of cancer occurrence in Turner syndrome

      ea0063oc14.5
• Guided Posters
• • Adrenal and Neuroendocrine - Tumour
  • • 68Ga-exendin-4 PET/CT detects insulinomas in patients with hypoglycemia in multiple endocrine neoplasia type 1

      ea0063gp1
    • Lanreotide therapy vs wait-and-see in patients with pancreatic neuroendocrine tumors

      ea0063gp2
    • ProGRP is an effective marker for disease monitoring in lung carcinoids with non-informative chromogranin A: Lessons from clinical practice

      ea0063gp3
    • Two cases of pseudopheochromocytoma due to Obstructive sleep apnea: which mechanisms?

      ea0063gp4
    • Pheochromocytoma's of MENX rats belong to the pseudo-hypoxia cluster

      ea0063gp5
    • Cellular modelling of SDH-associated pathomechanism of pheochromocytomas and paragangliomas

      ea0063gp6
    • Parafibromin is regulated by ubiquitin specific protease 37 (USP37) and the c-terminus of USP37 interacts with the beta-catenin binding region of CDC73 in hyperparathyroidism-jaw tumor syndrome

      ea0063gp7
    • Pheochromocytoma: Positive predictive values of mildly-elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients

      ea0063gp8
    • IGF-1 splice variants' expression in adrenal gland neoplasms- Possible role in adrenal tumorigenesis

      ea0063gp9
    • Brown fat proliferation- A rare complication of Phaeochromocytoma

      ea0063gp10
    • Corticotropinoma as the underlying cause of intermittent Cushing's syndrome in a patient previously diagnosed with primary pigmented adrenocortical disease (PPNAD) - a case report

      ea0063gp11
    • Functional mixed oncocytic adrenocortical neoplasm presenting as an asymptomatic adrenal mass

      ea0063gp12
    • KCTD20, a new gene in cortisol-secreting adrenocortical tumors related to inactivating mutations of the Carney Complex gene (PRKAR1A)

      ea0063gp13
    • Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) as a novel therapeutic approach in highly-selected pancreatic functioning and non-functioning neuroendocrine neoplasms (pNENs) patients: Preliminary report

      ea0063gp14
  • Calcium and Bone 1
  • • Recombinant human parathyroid hormone 1-84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study

      ea0063gp15
    • The effect of parathyroidectomy on glucose homeostasis and incretin hormone release in patients with primary hyperparathyroidism: a pilot study

      ea0063gp16
    • Utility of a second technecium99mMIBI-SPECT imaging before re-operating in patients with persistent sporadic primary hyperparathyroidism: results of a retrospective multicentric study

      ea0063gp17
    • Calcium to Phosphorus (Ca/P) ratio as an accurate index for the diagnosis of primary hyperparathyroidism (PHPT) and hypoparathyroidism (HypoPT)

      ea0063gp18
    • 18F-Fluorocholine PET/CT in patients with primary Hyperparathyroidism and negative or inconclusive 99mTc-MIBI parathyroid scan: clinico-pathological correlations

      ea0063gp19
    • Clinical, biochemical and radiological profile of normocalcaemic hyperparathyroidism: a multicentric cross-sectional evaluation

      ea0063gp20
    • The long-term outcomes of chronic post-surgical hypoparathyroidism

      ea0063gp21
    • OFELIA - Prevalence of osteoporosis in fragility fracture patients

      ea0063gp22
    • Study of hsa-miR-30e miRNA as a biomarker in identifying multiple gland disease in sporadic primary hyperparathyroidism: Is it time for individualized molecular-based surgery?

      ea0063gp23
    • The impact of impaired calcium-phosphorus metabolism on the renin-angiotensin-aldosterone system in patients with primary hyperparathyroidism

      ea0063gp24
    • Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey

      ea0063gp25
  • Diabetes and Cardiovascular Disease
  • • Association of MR-proANP with cardiovascular risk factors in middle aged patients with diabetes mellitus type 2 and non-diabetic controls

      ea0063gp26
    • Serum insulin levels are associated with vulnerable plaque components in the carotid artery

      ea0063gp27
    • The synergistic impact of apolipoprotein B/ A-1 and lipoprotein (a) on coronary artery calcification

      ea0063gp28
    • Systematic screening of masked hypertension in normotensive type 2 diabetic patients

      ea0063gp29
    • Cardiovascular risk factors in patients with type 2 diabetes and non-alcoholic fat liver disease

      ea0063gp30
    • Abstract unavailable

      ea0063gp31
    • Breastfeeding is inversely associated with subclinical atherosclerosis in postmenopausal women

      ea0063gp32
    • Application of 3D skin culture model as a tool to study the role of immune mechanisms in chronic diabetic foot ulcers pathogenesis

      ea0063gp33
    • Stroke in diabetic patients and cardiovascular risk factors control

      ea0063gp34
    • Cardiovascular biomarkers and calculated risks - an association study

      ea0063gp35
    • Family education, quality of life and glycosylated haemoglobin control among Nigerian diabetics: a quasi-experimental study

      ea0063gp36
  • Metabolic Syndrome and Hypoglycaemia
  • • Abstract unavailable

      ea0063gp37
    • Beta cell senescence: effect of glucotoxicity and glucolipotoxicity

      ea0063gp38
    • Generalized lipodystrophy associated with delayed neuro-somatic development and multiple dysmorphisms in a neonate with a compound heterozygous missense mutation in the SYNE2 gene

      ea0063gp39
    • Long-term administration of Empagliflozin may promote hepatic and renal lipid accumulation, and inflammation in the APOE knockout model

      ea0063gp40
    • Applying the Bradford Hill criteria to evaluate the association between hypoglycaemia and cardiovascular events/mortality (CVEM) [Data from meta-analysis (MA), Randomized Controlled Trials (RCTs), and observational outcome studies (OBS)]

      ea0063gp41
    • Magnitude of effects of testosterone replacement therapy on testosterone normalization, parameters of metabolic syndrome and vascular function and morphology in obese hypogonadal patients with type 2 diabetes - the SETH2 study

      ea0063gp42
    • The elevated chemerin plasma concentrations in men diagnosed with metabolic syndrome are correlated with markers of low-grade state inflammation but not with SHBG serum levels and accompanying hypoandrogenemia.

      ea0063gp43
    • Effects of anti-inflammatory treatment on fibroblast growth factor-21 in obesity and metabolic syndrome

      ea0063gp44
    • Hypoglycemia and dementia risk in older patients with type 2 diabetes: a propensity-score matched analysis of a population-based cohort study

      ea0063gp45
    • Characteristics and management of Type 1 diabetes mellitus patients with diabetic ketoacidosis

      ea0063gp46
    • Awareness, treatment rates and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable and definite familial hypercholesterolemia

      ea0063gp47
  • Acromegaly and GH
  • • Prolonged diagnostic delay in acromegaly is associated with long-term morbidity and excess mortality: data from a nationwide study

      ea0063gp48
    • Pharmacokinetics of somapacitan in individuals with renal impairment: an open-label, parallel group, phase 1 study

      ea0063gp49
    • Sleep disorders and cognitive dysfunction in acromegaly

      ea0063gp50
    • Prognostic value of short-acting pasireotide test for response prediction to pasireotide LAR in patients with acromegaly resistant to first-generation analogs. Can a short-acting pasireotide test predict the response of long-acting pasireotide treatment in patients with acromegaly resistant to first generation somatostatin analogs?

      ea0063gp51
    • Final height in childhood onset hypopituitarism

      ea0063gp52
    • Efficacy and safety of once-weekly somapacitan in adult growth hormone deficiency (AGHD) confirmed in a 53-week REAL-1 trial extension

      ea0063gp53
    • Pharmacokinetics in patients with prolactinomas

      ea0063gp54
    • Acromegaly do not increase the risk of vertebral fractures: a retrospective and prospective study on 50 patients

      ea0063gp55
    • Sclerostin and fracture risk assessment in acromegaly

      ea0063gp56
    • Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

      ea0063gp57
    • ACROSTUDY - safety and efficacy in a cohort of 110 Naive patients with acromegaly treated with pegvisomant

      ea0063gp58
    • Effects of pegvisomant and pasireotide LAR on incidence of vertebral fractures in patients with acromegaly resistant to treatment with first-line somatostatin analogs

      ea0063gp59
    • Metabolic outcome in adolescents with growth hormone deficiency during transition phase

      ea0063gp60
  • Reproductive Axis
  • • Novel phenotype of isolated diminished ovarian reserve and new CSB-PGBD3 (ERCC6) mutations revealed by targeted next generation sequencing in a cohort of caucasian infertile women

      ea0063gp61
    • Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3

      ea0063gp62
    • A KISS1R gene variant in a pedigree with maternally inherited precocious puberty

      ea0063gp63
    • Untargeted lipidomics profiling by high-performance liquid chromatography/time-of-flight mass spectrometry in polycystic ovary syndrome: candidate biomarkers and association to disease traits

      ea0063gp64
    • Testosterone replacement therapy outcomes in subjects with Klinefelter syndrome: preliminary results from a meta-analysis study

      ea0063gp65
    • Diet patterns in patients with PCOS

      ea0063gp66
    • MRI-based proton-density fat fraction measurements reveal alterations of abdominal fat, bone and muscle composition in lean women with PCOS

      ea0063gp67
    • DHT, rather than free testosterone, influences symptoms of aging in eugonadal men

      ea0063gp68
    • Male patients with hypogonadism have an impaired lipoprotein function

      ea0063gp69
  • Thyroid Autoimmune Disorders
  • • Serum levels of the soluble receptor for advanced glycation end products (AGEs) are reduced and AGEs increased in hashimoto's thyroiditis (HT)

      ea0063gp70
    • The randomised probiotic trial of indigo study (investigation of novel biomarkers and definition of role of the microbiome in Graves' orbitopathy)

      ea0063gp71
    • Microarray profile of CD19+B cells from Graves' disease patients reveals potential molecular mechanisms associated with the proliferation of B cell signaling

      ea0063gp72
    • Clinical experiences in autoimmune polyglandular diseases

      ea0063gp73
    • The change of pulmonary artery pressure and serum vascular endothelial growth factor in Graves' disease before and after treatment

      ea0063gp74
    • Grave's orbitopathy: clinical, paraclinical and therapeutic features

      ea0063gp75
    • Cardiovascular risk factors, autoimmunity and insulin resistance in Graves disease

      ea0063gp76
    • Lipid profile, insulin resistance and cytokines evaluation in autoimmune thyroiditis patients

      ea0063gp77
    • Autoimmune thyroiditis, Graves' disease and adiponectin, resistin and plasminogen activator inhibitor-1 levels

      ea0063gp78
    • The neutrophil-to-lymphocyte ratio as a novel marker in patients with thyroid-associated orbitopathy - a prelimininary study

      ea0063gp79
    • Effect of nine months of vitamin D supplementation on muscle performance in Graves' disease: a double-blinded, randomized clinical trial

      ea0063gp80
    • Retrospective analysis of the efficacy of three different dose regimens of rituximab in patients with active moderate-severe graves' orbitopathy

      ea0063gp81
  • Thyroid Nodules and Cancer
  • • Coexistence of the BRAF V600E and TERT promoter mutations and their impact on response to therapy and final outcome of papillary thyroid cancer

      ea0063gp82
    • Prognostic significance of TERT promoter and BRAF mutations in cytologically suspicious or malignant thyroid nodules: a monocentric case series at a tertiary-level endocrinology unit

      ea0063gp83
    • Polygenic susceptibility to papillary thyroid cancer: detection of the main genetic signature in Italian patients

      ea0063gp84
    • Follistain-like 1 (Fstl1) may reduce metastastic activity of anaplastic thyroid cancer by increasging thyroid transcription factor 1 (TTF1) and epithelial gene markers

      ea0063gp85
    • Benefits and limitations of TKIs in patients with medullary thyroid cancer: a systematic review and meta-analysis

      ea0063gp86
    • Intronic RAS and PI3KCA mutations identified by Next Generation Sequencing in thyroid nodules with indeterminate cytology may associate with follicular thyroid cancer

      ea0063gp87
    • An analysis of false-positive uptake on radioiodine whole-body scintigraphy

      ea0063gp88
    • Prospective sonographic assessment of 214 consecutive nodules as per the ATA 2015 guidelines. Real world data

      ea0063gp89
    • Treatment modalities in DTC patients with neck disease persistence. Second surgical intervention is more beneficial than only radioiodine (RAI) treatment

      ea0063gp90
    • Detection of EIF1AX>, CHEK2 and PPM1D gene variants in thyroid carcinomas

      ea0063gp91
    • Diagnostic performance evaluation of a computer-assisted imaging analysis system for ultrasound risk stratification of thyroid nodules

      ea0063gp92
    • Tirads classification and final diagnosis of thyroid nodules classified as bethesda-3 after fine-needle aspiration

      ea0063gp93
  • Adrenal and Neuroendocrine - Basic
  • • Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells

      ea0063gp94
    • The role of filamin A (FLNA) in the regulation of IGF2/IGF1R pathway in adrenocortical carcinomas

      ea0063gp95
    • An unusual association of P450 oxidoreductase Deficiency and Argininosuccinatelyase Deficiency

      ea0063gp96
    • Structural changes in the zona glomerulosa of normal aging adrenals

      ea0063gp97
    • Methylation status and gene expression of steroidogenic enzymes in benign adrenocortical tumors

      ea0063gp98
    • Implementation of two preclinical ACC models for a comparative drug screen and initial mechanistic investigations

      ea0063gp99
    • Characterization of cell death induced by mitotane in adrenocortical carcinoma cells

      ea0063gp100
    • Infiltrating CD68+/CD163+ macrophages regulate Gonadotroph-tumour invasion through collagen remodelling

      ea0063gp101
    • Development of a simple experiment to distinguish ARMC5 missense mutants from rare ARMC5 polymorphisms in PBMAH patients using a quantitative western blot approach

      ea0063gp102
    • Abstract unavailable

      ea0063gp103
    • Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas

      ea0063gp104
    • Reappraisal of the human adrenal cortex and fate

      ea0063gp105
    • Gene expression changes in visceral adipose tissue of Cushing syndrome.

      ea0063gp106
    • Abstract unavailable

      ea0063gp107
  • Calcium and Bone 2
  • • Exploring the mechanism of TGF-[beta]1 signaling in counteracting BMP activities during the osteogenesis of mesenchymal stem cells

      ea0063gp108
    • Sex steroids as determinants of Wnt-Signalling markers in men

      ea0063gp109
    • Denosumab in post-liver transplantation osteoporosis: preliminary data on the effects on bone mineral density and turnover markers

      ea0063gp110
    • Hip structure analyses in acromegaly: Decrease of cortical bone thickness after treatment

      ea0063gp111
    • Body composition determines muscle strength in osteoporotic patients with vertebral fractures

      ea0063gp112
    • Vertebral fracture in outpatients with type 2 diabetes mellitus

      ea0063gp113
    • Qualitative and quantitative parameters of diabetic osteopathy in type 1 diabetes mellitus

      ea0063gp114
    • Different impact of marrow and visceral adipose tissue on bone phenotype

      ea0063gp115
    • FGF-23 beyond the kidney: a new bone mass regulator in the general population

      ea0063gp116
    • Bone health and final height in craniopharyngioma patients.

      ea0063gp117
    • Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1

      ea0063gp118
  • Diabetes: Late Complications
  • • Glycemic variability and mortality in patients hospitalized to general surgery wards

      ea0063gp119
    • High prolactin levels within the normal range are associated with improved metabolic profile and lower carotid intima media thickness in premenopausal women

      ea0063gp120
    • The A allele of the rs4636297 (G/A) polymorphism in the microRNA-126 is associated with protection for diabetic retinopathy

      ea0063gp121
    • Vitamin D supplementation and dynamics of LDF skin microcirculation in patients with diabetes mellitus and diabetic polyneuropathy

      ea0063gp122
    • Four out of five patients with type 2 diabetes mellitus have hearing loss

      ea0063gp123
    • Unrecognized high risk for diabetic foot ulcer among hospitalized patients

      ea0063gp124
    • Vitamin D3 deficiency is associated with more severe insulin resistance and metabolic profile in patients with type 2 diabetes

      ea0063gp125
    • Depression and associated risk factors in older adults with diabetes: the 2010-2011 Korean national health and nutrition examination survey

      ea0063gp126
    • Genetic polymorphisms in patients with type 2 diabetes mellitus and coronary heart disease

      ea0063gp127
    • Clinical and metabolic characteristics of a population of diabetic patients previously educated having fasted all month of Ramadan

      ea0063gp128
    • Efficiency of application of silicate sorbents in surgical treatment of patients with neuro-ischemic form of diabetic foot ulcer

      ea0063gp129
  • Obesity
  • • Glucagon activity in human adipose precursors

      ea0063gp130
    • A Study of the Effect of Laparoscopic Mini Gastric Bypass Versus Sleeve Gastrectomy On Obese Type 2 Diabetic Patients

      ea0063gp131
    • Variants in genes of the leptin / melanocortin pathway are involved in 3% of cases of early-onset severe obesity

      ea0063gp132
    • Effect of IL1-receptor antagonist on renin-angiotensin-aldosterone system and hemodynamics in obese individuals

      ea0063gp133
    • Higher habitual intakes of dietary carbohydrates are associated with leptin gene expression in visceral and subcutaneous adipose tissues among non-diabetic people

      ea0063gp134
    • Obesity is associated with a downregulation of UCP2 and miR-133a-3p but not NLRP3 in subcutaneous adipose tissue

      ea0063gp135
    • Administration of a growth hormone bolus down-regulates gene-expression of the g0/g1 switch gene 2 (g0s2) in subcutaneous adipose tissue in healthy, obese men: a randomized, placebo-controlled, cross-over study

      ea0063gp136
    • Empagliflozin as well as Anakinra reduce symptomatic hypoglycemia in patients after Roux-Y-gastric bypass by lowered insulin secretion

      ea0063gp137
    • Androgen metabolism during weight loss in men with obesity

      ea0063gp138
    • Prediction of clinically significant weight loss with Gelesis100 in the GLOW study as early as 8 weeks post-treatment

      ea0063gp139
    • The efficacy of complex kinesiotherapy in weight loss and muscle function improving in obesity patients

      ea0063gp140
    • Dietary inflammatory index is differently associated with ectopic fat depots in overweight and obese adults

      ea0063gp141
  • Interdisciplinary Endocrinology 1
  • • Impact of age and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult male cohort

      ea0063gp142
    • Impact of age, menstrual phase, menopausal status and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult female cohort

      ea0063gp143
    • Bilateral femoral head necrosis with low dose oral corticosteroid therapy for pan-hypopituitarism

      ea0063gp144
    • Final (FH) and target height (TH) in male and female patients with congenital hypogonadotropic hypogonadism (CHH)/Kallmann syndrome (KS): a monocentric study of 216 patients

      ea0063gp145
    • Turner syndrome: mental health and social skills from childhood to emerging adulthood

      ea0063gp146
    • Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp147
    • Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp148
    • Risk of chronic kidney disease (CKD) and CKD progression in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

      ea0063gp149
    • Increased prevalence of overweight and obesity and its clinical predictors in children affected by x-linked hypophosphatemia

      ea0063gp150
    • MEN4: is there a link with autoimmunity?

      ea0063gp151
    • UMD-MEN1 database: analysis of clinical and genetic data from 1,676 patients by the TENGEN network

      ea0063gp152
  • Cushing's
  • • Evaluation of the corticotrophin-releasing-hormone test and the high dose dexamethasone suppression test in ACTH dependent Cushing's syndrome: a 25-year prospective cohort study

      ea0063gp153
    • Pathway enrichment analysis in functioning and silent corticotroph pituitary adenomas reveals mechanisms to explain their distinct clinical behaviour

      ea0063gp154
    • Endocrine immune-related adverse events following immune checkpoint inhibitors in patients with advanced melanoma: single-center retrospective analysis

      ea0063gp155
    • Correlation between responsiveness to CRH stimulation test in Cushing's disease patients and USP8 mutational status

      ea0063gp156
    • DNA Methylation and fMRI responses in patients with Cushing's syndrome in remission - suggestions of a functional link between hypercortisolism and neurocognitive dysfunction

      ea0063gp157
    • Cortisol and cortisone assays in hair by mass spectrometry for the diagnosis of Cushing's syndrome

      ea0063gp158
    • Skeletal muscle fatty infiltration in the thigh, as assessed by MRI T2-weighted and 3-point Dixon sequences, is associated with poor performance on muscle function testing in patients with Cushing's syndrome in remission

      ea0063gp159
    • Brain 18F-fluorodeoxyglucose PET/CT in localization of MRI-negative ACTH-producing pituitary adenomas

      ea0063gp160
    • Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells

      ea0063gp161
    • Pharmacokinetics of osilodrostat following single and multiple doses of osilodrostat in healthy subjects and patients with Cushing's disease

      ea0063gp162
    • Effects of a single dose of pasireotide on glucose metabolism in patients with Cushing's disease and predictors of diabetes mellitus developement during treatment

      ea0063gp163
    • Assessment of bone marrow fat by single-voxel vertebral magnetic resonance spectroscopy in cushing's syndrome with or without vertebral fractures

      ea0063gp164
  • Obesity (1)
  • • Role of invasive and non-invasive diagnostic tests in differential diagnosis of ACTH-dependent Cushing's syndrome

      ea0063gp165
    • Results from the phase 3 multicenter SONICS study of levoketoconazole: subgroup analysis of Cushing's syndrome patients with diabetes mellitus

      ea0063gp166
    • Epigenetic regulation by miRNAs in corticotroph tumors

      ea0063gp167
    • Evaluation of utility of salivary cortisol levels after suppression with 1 mg Dexamethasone in screening of Cushing's syndrome

      ea0063gp168
    • The role of copeptin and cortisol in critically ill patients

      ea0063gp169
    • Microstructural white matter changes using diffusion tensor imaging in patients with Cushing's disease

      ea0063gp170
    • A new generation somatostatin-dopamine chimeric analogue exerts potent antitumoral actions on primary pituitary neuroendocrine tumor cells

      ea0063gp171
    • Pituitary surgery as first-line therapy for microprolactinomas

      ea0063gp172
    • Excellent tumor response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

      ea0063gp173
    • Sleep disorders after craniopharyngioma surgery

      ea0063gp174
    • Normal IGF-bioactivity and low free IGF-I in patients with Prader-Willi syndrome with high total serum IGF-I: immunoreactive IGF-I concentrations poorly reflect IGF bio-activity and bio-availability

      ea0063gp175
  • Benign Thyroid Disorders
  • • Do different initial doses of L-T4 within the range of 10-15 mcg/kg/die influence neurodevelopment during the first two years of life in children with congenital hypothyroidism?

      ea0063gp176
    • Abstract unavailable

      ea0063gp177
    • Cystic fibrosis as a novel cause of thyroxine (l-t4) malabsorption and increased requirement

      ea0063gp178
    • Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II

      ea0063gp179
    • Urinary concentration of iodotyrosines correlates with the severity of iodine deficiency in dehal1 knockout mice

      ea0063gp180
    • Effect of anti-streptavidin interference when diagnosing thyroid disease using immunoassay analyses

      ea0063gp181
    • Can hepcidin be a useful marker in the diagnosis and monitoring of de Quervain thyroiditis?

      ea0063gp182
    • High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study

      ea0063gp183
    • Effect of restoration of thyroid function on body composition, insulin resistance and visfatin concentrations in women with hypo- and hyperthyroidism

      ea0063gp184
    • Thyroid-related adverse events in patients treated with Nivolumab and Pembrolizumab

      ea0063gp185
    • Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus

      ea0063gp186
  • Adrenal and Neuroendocrine - Clinical
  • • Primary adrenal insufficiency in children: results from a large nationwide cohort

      ea0063gp187
    • Increased risk of infections in Addison's disease and congenital adrenal hyperplasia patients: a longitudinal study based on a United Kingdom primary care database

      ea0063gp188
    • Plasma renin concentration is associated with cardiac function and morphology in primary adrenal insufficiency

      ea0063gp189
    • Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study

      ea0063gp190
    • Pneumocystis pneumonia as a major complication of medical treatment for severe Cushing's syndrome linked either to ectopic ACTH secretion or to Cushing's disease

      ea0063gp191
    • Diagnostic accuracy of captopril challenge test and saline infusion test in patients at high risk for primary aldosteronism

      ea0063gp192
    • Comparison of whole-genome expression analysis in patients with secondary adrenal insufficiency treated with conventional treatment versus modified-release hydrocortisone

      ea0063gp193
    • New perioperative imaging techniques, immunohistochemistry and genetic analysis to investigate the suitability of laparoscopic partial adrenalectomy in primary aldosteronism

      ea0063gp194
    • Evaluation of clinical and biochemical cure and adrenal CYP11B2 and CYP11B1 immunostaining in primary aldosteronism operated after adrenal venous sampling

      ea0063gp195
    • Sexual function in adrenal insufficiency: data from the DREAM trial

      ea0063gp196
    • Optimizing mineralocorticoid replacement therapy in patients with congenital adrenal hyperplasia and Addison's disease

      ea0063gp197
    • Analysis of circulating microRNAs in primary aldosteronism

      ea0063gp198
    • LC-MS/MS measurement for urinary aldosterone improves primary aldosteronism screening

      ea0063gp199
  • Diabetes: Pharmacotherapy
  • • A liver selective knockdown of Dpp4 by therapeutic siRNA affects lipid metabolism but fails to improve glucose control in diabetic mice

      ea0063gp200
    • Blood intact incretin levels are related to beta-cell function and glycemia in patients with type 2 diabetes

      ea0063gp201
    • The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin

      ea0063gp202
    • Effects of cardiovascular function of SGLT-2 inhibitos versus DPP-4 inhibitors in type 2 diabetes with coronary artery disease

      ea0063gp203
    • Fasting insulin levels correlate with the incidence of hypoglycemic events in patients with Type 2 Diabetes treated with sulfonylureas: a retrospective cross-sectional study

      ea0063gp204
    • Metabolic changes in men undergoing androgen deprivation therapy for prostate cancer

      ea0063gp205
    • Antioxidant and hypoglycemic effects of gossitan

      ea0063gp206
    • Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes

      ea0063gp207
    • Effects of glucagon-like peptide 1 receptor agonist on short-chain fatty acids, carbohydrate and lipid metabolism in patients with type 2 diabetes

      ea0063gp208
    • Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital

      ea0063gp209
    • Empagliflozin inhibits apoptosis of pancreatic beta-cells through amelioration of ER-stress.

      ea0063gp210
    • New insights on strain-specific impacts of probiotics on insulin resistance

      ea0063gp211
  • Gestational and Type 1 Diabetes
  • • Prevalence of gestational diabetes during 14 pregnancies of acromegalic women

      ea0063gp212
    • The impact of the intrauterine hyperglycaemia on the expression of genes related to cardio-metabolic diseases in human umbilical vein endothelial cells: results from a randomised, controlled study of different glycaemic targets during gestational diabetes treatment

      ea0063gp213
    • Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study

      ea0063gp214
    • Brain volume and variability of glycemia in patients with type 1 diabetes mellitus

      ea0063gp215
    • Specific pattern of insulin delivery during pregnancy in tightly controlled type 1 diabetic patients treated with insulin pump; unchanged total daily insulin dose per kilogram with consecutive basal/prandial insulin ratio adjustment

      ea0063gp216
    • The rs2304256 A allele in the TYK2 gene is associated with protection for type 1 diabetes mellitus in a Brazilian population

      ea0063gp217
    • Effect of HbA1c and hyperglycemia on hemostasis in patients with type 1 diabetes

      ea0063gp218
    • Impact of type 1 diabetes mellitus and its complications on markers of nitric oxide metabolism

      ea0063gp219
    • Definition of a third-trimester HbA1c cut-off point for an increased risk of Large-for-Gestational-Age in mothers with Gestational Diabetes

      ea0063gp220
    • Insulin requirements during lactation in women with diabetes mellitus type 1 in comparison with pre-pregnancy levels - a retrospective study

      ea0063gp221
    • The impact of gestational weight gain on subclinical atherosclerosis, placental circulation and neonatal complications

      ea0063gp222
  • Adrenal and Neuroendocrine - Clinical (1)
  • • Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosis

      ea0063gp223
    • Caffeine upregulates hepatic SHBG production by increasing adiponectin in white adipose tissue

      ea0063gp224
    • Activation of the ATM/Akt/CREB/eNOS expression signaling axis by aphidicolin increases nitric oxide production to attenuate endothelial cell death

      ea0063gp225
    • Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - final Results of the phase 0 'Lumed' Study

      ea0063gp226
    • Multikinase inhibitors for the treatment of progressive, metastatic parathyroid cancer

      ea0063gp227
    • Serine-threonine PAK1 as a novel common node for estrogen- and prolactin-dependent pathways in breast cancer

      ea0063gp228
    • Melatonin prevented beta cell senescence against glucolipotoxicity

      ea0063gp229
    • Low-dose pollutant mixture triggers metabolic disturbances in ovariectomized mice and comparison with the effects of 17[beta]-estradiol (E2) treatment

      ea0063gp230
    • In vitro effects of bisphenol A and its analogs on human melanocortin 4 receptor

      ea0063gp231
    • Can phthalates impair liver function?

      ea0063gp232
  • Anterior and Posterior Pituitary
  • • Evaluation of postoperative copeptin concentration as a predictive factor of diabetes insipidus after pituitary surgery. preliminary results

      ea0063gp233
    • Is the molecular study of pituitary transcription factors useful in the identification of Pituitary Neuroendocrine Tumor subtypes according to the new WHO 2017 criteria?

      ea0063gp234
    • The effect of previous optic chiasm compression on the post-illumination pupil response in pituitary patients

      ea0063gp235
    • Characteristics and natural history of a large cohort of non-functioning pituitary incidentalomas: a two-centers study

      ea0063gp236
    • Diagnostic accuracy of copeptin in the diagnosis of diabetes insipidus after pituitary surgery

      ea0063gp237
    • Immune checkpoint inhibitors therapy-induced hypophysitis is frequently associated with previous thyroid disorders: results from ImmuCare study

      ea0063gp238
    • Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature

      ea0063gp239
    • Adrenal axis deterioration in the families/sporadic patients with PROP1 mutation, over 30 years of single center longitudinal observation

      ea0063gp240
    • Inflammatory response to osmotic stimulus in healthy volunteers

      ea0063gp241
    • Copeptin levels in SIADH - a marker of malignant disease?

      ea0063gp242
    • Histological classification of pituitary neuroendocrine tumors: genomic insights on cell lineage

      ea0063gp243
    • Tomosyn negatively regulates arginine vasopressin secretion in embryonic stem cell-derived neurons

      ea0063gp244
  • Disturbances of Reproduction
  • • MRI detection of aortic anomalies in 204 adult patients with Turner syndrome: a longitudinal study

      ea0063gp245
    • Is monosomia related to poorer cardiometabolic state in Turner syndrome?

      ea0063gp246
    • The efficacy of long-term metformin treatment in overweight and obese women with PCOS: A 10-year database study

      ea0063gp247
    • Gut microbiota-dependent cardiometabolic risk and oral contraceptive use in polycystic ovary syndrome: A prospective study

      ea0063gp248
    • Maternal 3rd trimester cortisol status was associated with offspring sex and PCOS status. Odense Child Cohort

      ea0063gp249
    • Diagnostic potential of a 'mouse azoospermia' gene panel in human azoospermia: identification of novel genetic causes of meiotic arrest

      ea0063gp250
    • Free Testosterone (FT) is inversely related to frailty in Human Immunodeficiency Virus (HIV)-Infected Men

      ea0063gp251
    • Prolactin and prostate: an observational case-control study in men with prolactinoma under cabergoline treatment

      ea0063gp252
    • Genetic architecture of greek patients with isolated GnRH deficiency

      ea0063gp253
  • Thyroid Nodules and Cancer 2
  • • Recurrent laryngeal nerve liberation technique for phonation recovery

      ea0063gp254
    • Are clinicopathological features of isthmic thyroid nodules different from nodules located in thyroid lobes?

      ea0063gp255
    • Impact of age at the diagnosis of radioiodine resistance in differentiated thyroid cancer patients

      ea0063gp256
    • Effects of hospital volume on clinical outcomes after thyroidectomy - a Swiss nation-wide study

      ea0063gp257
    • Predictors of malignancy in thyroid FNA classified as high-risk indeterminate lesions (TIR3B): combining ultrasonographic and cytology features

      ea0063gp258
    • Sentinel lymph node biopsy using methylene blue dye in clinically N0 papillary and medullary thyroid carcinomas for decision on one-time lateral neck dissection

      ea0063gp259
    • Factors influencing nodular goiter - An analysis of the growth rates in long-term follow-up patients

      ea0063gp260
    • Evaluating effects of thyrotrophin receptor antibody positivity on cytology and histopathology in patients with graves disease

      ea0063gp261
    • Classification of thyroid nodules by ultrasound in clinical practice: the added value of the judgment of the skilled endocrinologist

      ea0063gp262
    • Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience

      ea0063gp263
    • Assessment of different ti-rads systems using computer-aided detection technology

      ea0063gp264
• Poster Presentations
• • Adrenal and Neuroendocrine Tumours 1
  • • A novel heterozygous mutation in exon 3 of VHL gene leading to Von Hippel-Lindau disease in a Turkish family

      ea0063p1
    • Long evolution of Connshing syndrome?

      ea0063p2
    • Effect of Glucocorticoid receptor antagonist administration in a Cushing's syndrome model rat

      ea0063p3
    • Ectopic adrenocorticotropic hormone (ACTH-ectopic) syndrome and osteoporosis: Rare cases and difficult treatment

      ea0063p4
    • Paraganglioma of the urinary bladder wall: 2 cases with 2 different presentations

      ea0063p5
    • Adrenal insufficiency secondary to bilateral adrenal diffuse large B-cell lymphoma: a case report

      ea0063p6
    • A rare association of Adrenocortical carcinoma with haematological and breast malignancy in a young female

      ea0063p7
    • Metabolic and cardiovascular profile of 143 adrenal incidentalomas

      ea0063p8
    • HNRNP Q suppresses polyglutamine huntingtin aggregationby post-transcriptional regulation of Vaccinia-related kinase 2

      ea0063p9
    • Study of body composition and phase angle in relation to nutritional parameters in patients with neuroendocrine tumors

      ea0063p10
    • A case series of two patients with intrapericardial paragangliomas

      ea0063p11
    • Combined autophagy and mTOR inhibition reduces cells proliferation and induces apoptosis in a lung carcinoid in-vitro model

      ea0063p12
    • Pheochromocytoma - 3 sides of the same story

      ea0063p13
    • Analysis of the 22-years experience of surgical treatment of adrenal tumor in single specialized endocrinological center

      ea0063p14
    • Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism

      ea0063p15
    • Cortex protecting surgery in MEN 2A

      ea0063p16
    • Unilateral non-haemorrhagic adrenal infarction (NHAI) as a cause of abdominal pain during pregnancy

      ea0063p17
    • Evaluating the applicability of urinary miR-483-5p as a non-invasive marker in adrenocortical cancer patients

      ea0063p18
    • Allgrove syndrome (Triple A syndrome): A case report

      ea0063p19
    • A case series of metastatic pheochromocytomas and paragangliomas: patients characteristics, therapeutic approach and follow-up

      ea0063p20
    • Retroperitoneal paraganglioma: clinical case

      ea0063p21
    • The frequency of confirmed primary hyperaldosteronism in patients with high aldosteron renin ratio

      ea0063p22
    • Evaluation of angiotensin II in primary aldosteronism and other forms of hypertension - a preliminary study

      ea0063p23
    • Management of adjuvant mitotane therapy for adrenocortical carcinoma: a survey in Italy

      ea0063p24
    • Management of mitotane for advanced adrenocortical carcinoma: a survey in Italy

      ea0063p25
    • How do sex and BMI affect glucocorticoid treatment in adrenal insufficiency?

      ea0063p26
    • Abstract unavailable

      ea0063p27
    • Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency

      ea0063p28
    • Pheocromocytoma, newly diagnosed during pregnancy in a subject with neurofibromatosis type 1: A case report and review of literature

      ea0063p29
    • Becoming of patients with primary aldosteronism according to their treatment

      ea0063p30
    • Predictors of bilateral and unilateral primary aldosteronism: a retrospective observational study

      ea0063p31
    • 18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status

      ea0063p32
    • Complete remission of a highly aggressive, metastasized, SDHB-related paraganglioma after chemotherapy with CVD and peptide-receptor radiotherapy

      ea0063p33
    • Aldosterone measurement in the Diagnosis of primary aldosteronism - comparison between two automated immunoassays and two liquid chromatography tandem mass-spectrometry methods

      ea0063p34
    • Embolization of the adrenal artery to control severe adrenal hemorrhage

      ea0063p35
    • Vitamin D deficiency is a predictor marker of tumor aggressiveness in sporadic and MEN1-related well-differentiated, low-grade GEP-NET

      ea0063p36
    • Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas

      ea0063p37
    • Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs

      ea0063p38
    • A novel CYP11B1 mutation presenting as a classical congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency

      ea0063p39
    • Available 3D cultures methods: study on a Pancreatic Neuroendocrine Neoplasm cell line

      ea0063p40
    • Prevalence and prognosis of bone metastases in pancreatic and small intestinal neuroendocrine tumours

      ea0063p41
    • Endocrine hypertension?

      ea0063p42
    • Ninety-four serum steroids measured by gas chromatography tandem mass spectrometry (GC-MS/MS) in patients with Cushing's syndrome

      ea0063p43
    • Comparative study between autoimmune metaplastic atrophic gastritis (AMAG) and type 1 gastric neuroendocrine tumors (G-NETs) in Hospital Clinico San Carlos (HCSC), Madrid

      ea0063p44
    • Pheochromocytoma and disorders of carbohydrate metabolism

      ea0063p45
    • Heart and vessels after a pheochromocytoma: which outcomes?

      ea0063p46
    • First presentation of Addison's disease as hyperkalaemia: a rare case report

      ea0063p47
    • Pharmacokinetic Interaction Study of the Effects of Multiple-dose Gastric Acid Reducers Omeprazole (OMP) and Famotidine (FAM on the Pharmacokinetics (PK) of Single-dose Telotristat Etiprate (TE) in Healthy Subjects

      ea0063p48
    • Endocrine hypertension: before and after treatment of the endocrinopathy

      ea0063p49
    • A seminoma with entrapped nerve ganglion masquerading as a paraganglioma

      ea0063p50
    • Magnetic resonance imaging in the initial diagnosis of pancreatic insulinoma: primary data analysis

      ea0063p51
    • Exome analysis of pituitary adenoma tissue derived cell cultures

      ea0063p52
    • A rare association of neuroendocrine tumor with adenocarcinoma of ampulla of vater: difficulties for diagnosis and effects of multi therapeutic approach

      ea0063p53
    • Continuous glucose monitoring during the prolonged fast test for the diagnosis of hypoglycemic diseases: primary data analysis

      ea0063p54
    • Clinical case of a repeated life-threatening upper gastrointestinal bleeding due to previously unknown primary hyperparathyroidism

      ea0063p55
    • A difficult diagnosis: pheochromocytoma or methamphetamine abuse?

      ea0063p56
    • Association of the BclI glucocorticoid receptor polymorphism with body composition and metabolic parameters in female patients with adrenal incidentalomas

      ea0063p57
    • A case of Von Hippel-Lindau disease with bilateral pheochromocytoma and ectopic hypersecretion of intact parathyroid hormone

      ea0063p58
    • Adrenal pheocromocytoma during childhood - a case report

      ea0063p59
    • Adrenal morphology in a large cohort of adult subjects with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0063p60
  • Calcium and Bone 1
  • • Vitamin D status and linear growth in a sample of Egyptian adolescents

      ea0063p61
    • The effectiveness of colecalciferol and selective vitamin D receptor agonists treatment on secondary hyperparathyroidism in chronic kidney diseases patients

      ea0063p62
    • Osteoporosis in developing-nations: need for centralized-data-collection & treatment-guidance centers to study epidemiology

      ea0063p63
    • Prevalence and the main risk factors for vitamin D deficiency in pregnant women living in a locality of Algiers

      ea0063p64
    • Effects of dexamethasone for calcium channels and mucin-related genes regulation on A549 cell line

      ea0063p65
    • Regulatory effect of dexamethasone on tracheal calcium processing proteins and mucosal secretion

      ea0063p66
    • The effect of steroid hormone on the expression of the calcium-processing proteins in the immature rat brain

      ea0063p67
    • Distribution of and steroid hormone effects on calbindin-D9k in the immature rat brain

      ea0063p68
    • Pledoary for using Trabecular Bone Score as a method for osteoporosis diagnosis, not only for the risk

      ea0063p69
    • Relationship between leptin level, body mass index and parathyroid hormone in chronic hemodialysis patients

      ea0063p70
    • Challenging clinical case of primary hyperparathyroidism caused by atypical adenoma

      ea0063p71
    • Severe hypocalcemia: when the skin expresses itself

      ea0063p72
    • Ultrasound detection of parathyroid hyperplasia in patients with chronic kidney disease treated by dialysis

      ea0063p73
    • Multiple fragility fractures in young female patients caused by FGF23-induced hypophoshatemic osteomalacia

      ea0063p74
    • Clinical significance of parathyroid incidentalomas during thyroidectomy: a South Indian experience

      ea0063p75
    • Value of ultrasonography guided fine-needle-aspiration in the diagnosis of an intrathyroidal parathyroid adenoma associated with thyroid pathology

      ea0063p76
    • The effect of parathyroidectomy on the BMD in postmenopausal women with mild primary hyperparathyroidism: the results of comparative retrospective dynamic study

      ea0063p77
    • Obstructive urolithiasis as first sign of primary hyperparathyroidism caused by a large parathyroid hyperplasia

      ea0063p78
    • Parathyroid adenoma in pregnancy: a case report

      ea0063p79
    • Effects of bariatric surgery on bone health

      ea0063p80
    • A rare case of hypoparathyroidism due to MELAS syndrome

      ea0063p81
    • A case report of tumor-induced osteomalacia

      ea0063p82
    • Pregnancy-related osteoporosis: a series of cases

      ea0063p83
    • Bone mineral density, prevalence of fractures, antiosteoporotic drugs effectiveness and Ca/Vit D supplementations intake in elder patients with osteoporosis: a cross-sectional study on Moscow population

      ea0063p84
    • Brown tumor of the palate as first manifestation of a primary hyperparathyroidism

      ea0063p85
    • Difference in trabecular bone score according to spine-femur bone mineral density discordances in healthy postmenopausal women

      ea0063p86
    • Heterogenous clinical presentation of primary hyperparathyroidism in Romania

      ea0063p87
    • A case of primary hyperparathyroidism due to a giant parathyroid adenoma extending into the mediastinum

      ea0063p88
    • Diagnostic and treatment delay in primary hyperparathyroidism (phpt): a pending issue

      ea0063p89
    • Epidemiology of hypoparathyroidism in Korea

      ea0063p90
    • Effectiveness of intramuscular Ergocalciferol treatment in a patient with o steomalaciadueto severe vitamin D deficiencyafterbariatric surgery

      ea0063p91
    • A rare case of hypercalcemia associated with dysgerminoma with elevation of 1,25(OH)2 Vitamin D

      ea0063p92
    • Analysis of non-invasive DXA-derived bone structure parameters in patients with acromegaly with regards to vitamin D levels

      ea0063p93
    • Osteitis Fibrosa Cystica - A Forgotten Clinical And Radiological Feature Of Primary Hyperparathyroidism

      ea0063p94
    • Clinical use of Cinacalcet in patients with complex primary hyperparathyroidism

      ea0063p95
    • A rare case of Graves' disease in a patient with type 1B pseudohypoparathyroidism and associated TSH resistance

      ea0063p96
    • Primary hyperparathyroidism: clinical manifistation in Russian population

      ea0063p97
    • The effect of vitamin D supplementation on sarcopenia indices: a systematic review and meta-analysis of randomized controlled trials

      ea0063p98
    • The factors affecting balance function in patients with osteoporotic vertebral fractures

      ea0063p99
    • Evaluation of trabecular bone score in men with type 1 diabetes

      ea0063p100
    • Association between body mass index and the risk of falls: a nationwide population-based study

      ea0063p101
    • Various clinical features of Digeorge syndrome

      ea0063p102
    • About a case of familial hypocalciuric hypercalcemia (FHH) type 3 with neurological involvement

      ea0063p103
    • Verified data on parathyroid hyperplasia incidence not related to primary hyperparathyroidism in persons exposed to ionizing radiation

      ea0063p104
    • Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies

      ea0063p105
    • Case Report of a large family with hyperparathyroidism- jaw tumor syndrome (HPT-JT) and a deletion of the third exon of CDC73

      ea0063p106
    • Pseudohypoparathyroidism- a tale of hypo- and hypercalcemia with a genetic solution

      ea0063p107
    • Generalized skeletal hyperostosis mimicking acromegaly

      ea0063p108
    • Evaluation of bone quality in acromegaly and thyrotoxicosis using trabecular bone score

      ea0063p109
    • Primary hyperparathyroidism and vitamin D

      ea0063p110
    • The coincidence of primary hyperparathyroidism and primary hyperaldosteronism is not infrequent: a retrospective case analysis

      ea0063p111
    • Bilateral hip fractures and osteoporosis in a 40-year old man - identification of a novel TMEM38 mutation causing osteogenesis imperfecta

      ea0063p112
    • Hypomagnesemia induced disturbance of consciousness in alcoholic cirrhosis

      ea0063p113
    • Is any body composition parameter a risk factor for symptomatic hypocalcemia after thyroidectomy?

      ea0063p114
    • Severe diffuse tissue calcifications in a patient with pseudohypoparathyroidism type 1 A due to a novel large deletion of GNAS gene

      ea0063p115
    • Successful removal of parathyroid cancer metastasis from VI thoracic vertebra

      ea0063p116
    • Primary Hyperparathyroidism: about 34 observations

      ea0063p117
    • The clinical spectrum and endocrine profile of pseudohypoparathyroidism: ACTH resistance should not be ignored

      ea0063p118
    • Biochemical and clinical features of a family with a novel mutation of CYP24A1

      ea0063p119
    • A case of primary hyperparathyroidism in a patient with Lobstein's disease

      ea0063p120
  • Diabetes, Obesity and Metabolism 1
  • • Lifestyle modification strategies to prevent diabetes in individuals who participated in a medical health check

      ea0063p121
    • Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus

      ea0063p122
    • Effects of lemon and cumin on premature atherosclerosis in obese patients

      ea0063p123
    • Management of acute charcot arthropathy

      ea0063p124
    • Non-Governmental Organizations (NGO's) & Diabetes - advocacy for support services in resource-poor nations

      ea0063p125
    • Microvascular and macrovascular complications in a cohort of patients with type 2 diabetes mellitus

      ea0063p126
    • Calbindin-D9k ablation cause endoplasmic reticulum stress induced [beta] cell death

      ea0063p127
    • Serum 25-hydroxycholecalciferol and the A allele of rs2228570 of the vitamin D receptor locus reduce the risk of type 2 diabetes mellitus in Jordan

      ea0063p128
    • Long term functional prognosis is worse in patients with chronic hyperglycemia

      ea0063p129
    • Role of blood catecholamine in cases with dysmetablolic iron overload syndrome (DIOS) in patients of Metabolic Syndrome

      ea0063p130
    • Incidence of obesity, overweight and hypertension in children and adolescents in Ahvaz southwest of Iran

      ea0063p131
    • Association of serum lipid profile and insulin resistance in polycystic ovary syndrome (PCOs) women in Ahvaz, Iran

      ea0063p132
    • A1c level in people with newly diagnosed type 2 diabetes during screening

      ea0063p133
    • Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men

      ea0063p134
    • The frequency of Cushing's disease, ACTH independent Cushing's syndrome, and autonomous cortisol secretion among turkish patients with obesity

      ea0063p135
    • Higher level of astrocyte elevated gene 1 expression in peripheral blood monocytes in adults with newly diagnosed type 2

      ea0063p136
    • The EMPA-REG OUTCOME, a real cardiovascular benefit or a play on words?

      ea0063p137
    • Diabetic nephropathy and arterial stiffness in patients with type 1 diabetes mellitus

      ea0063p138
    • Evaluation of perior-operational safety and efficiency of the laparoscopic gastroplication procedure compared to laparoscopic handle gasstroektomia in patients with overweight and metabolic syndrome

      ea0063p139
    • Predictors of incident hypertension in healthy, non-diabetic postmenopausal women with normal renal function

      ea0063p140
    • The role of sodium glucose co-transporter inhibitors in patients with acromegaly and diabetes: is there an additive effect beyond glucose control? A clinical hypothesis

      ea0063p141
    • Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications

      ea0063p142
    • Clinical importance of determination of glytoxic methylglyoxal in nafld and type 2 type

      ea0063p143
    • The psychometric adaptation of the Russian version of the Diabetes Eating Problem Survey-Revised (DEPS-R)

      ea0063p144
    • Retinol binding protein 4-marker insulin resistance in patients with diabetes mellitus 2 types and NAFLD

      ea0063p145
    • Metabolic profile and diabetes in prison

      ea0063p146
    • The treatment of fertile age women with obesity

      ea0063p147
    • Prevalence and risk factors of hepatic steatosis among patients with chronic hepatitis B

      ea0063p148
    • Negative regulation of AMPK-related kinase MPK38/MELK activity by protein phosphatase 5 (PP5)

      ea0063p149
    • Effects of diabetes mellitus and autoimmune thyroiditis on features of rheumatoid arthritis

      ea0063p150
    • 'Killing two birds with one stone' treating porphyria patient with diabetes with SGLT2 inhibitors - a case report

      ea0063p151
    • Effect of glucocorticoid on agouti-related protein deficient mice

      ea0063p152
    • Insulin content and activity of inflammatory markers in patients with nonalcoholic fatial liver disease and diabetes of the second type

      ea0063p153
    • The role of bile acids in the pathogenesis of NAFLD

      ea0063p154
    • Improvement of human pancreatic islet quality after co-culture with human adipose-derived stem cells

      ea0063p155
    • The association between lipoprotein (a) and metabolic syndrome

      ea0063p156
    • Relationship study between blood groups, rhesus factor and the risk of diabetes type 2 in a population of the Sidi Othmane district, Casablanca

      ea0063p157
    • Case-control study on the obesity prevalence in a population of diabetic's consultant at the health department of Sidi-Othmane district, Casablanca: Morocco

      ea0063p158
    • Vitamin D: cardiovascular risk marking? About 290 patients

      ea0063p159
    • Complementary-alternative medicine & diabetes treatment adherence

      ea0063p160
    • Diabetes and QOL: strategies we need to work on

      ea0063p161
    • The relationship between glycated hemoglobin, postload blood glucose levels and non-hdl cholesterol among 75 gram oral glucose tolerance test applied women

      ea0063p162
    • Diabetes-, sex-, and BMI specific associations of genetic variants in PRRG1 with cardiovascular surrogates in a large cohort at CV risk

      ea0063p163
    • CGI-58 gene expression is decreased in the subcutaneous adipose tissue of patients with obesity

      ea0063p164
    • Results at 2 years of bariatric surgery in patients with type 2 diabetes mellitus

      ea0063p165
    • Assessment of the functional activity of neutrophilic granulocytes in patients with metabolic syndrome

      ea0063p166
    • Hygienic-dietetic habits in a group of patients with morbid obesity waiting for bariatric surgery and in a group already intervened

      ea0063p167
    • Challenges in managing patients with type 1 diabetes and hypersensitivity reaction to insulin

      ea0063p168
    • Relationship between liver fibrosis and diabetes-related complications in type 2 diabetic patients

      ea0063p169
    • Study on compositions of lipids in tissues of rats with alimentary obesity

      ea0063p170
    • Dopamine Receptor and Dopamine Transporter in Obesity: A Meta-analysis

      ea0063p171
    • Cerebral glucose metabolism and Cerebral blood flow in Hypothyroidism and Hyperthyroidism: An activation likelihood estimation Meta-analysis

      ea0063p172
    • Biomarkers of myocardial fibrosis at coronary heart disease in the presence and absence of diabetes mellitus type 2

      ea0063p173
    • Prevalence of vitamin D deficiency in a population of patients with prediabetes and type 2 diabetes mellitus

      ea0063p174
    • Genealogical analysis in diabetes mellitus risk assessment

      ea0063p175
    • The waist-to-hip ratio is a better obesity index than body mass index and waist circumference for screening for nonalcoholic fatty liver disease in postmenopausal women

      ea0063p176
    • The severity of different components of metabolic syndrome in hypertensive patients depending on IRS-1 gene polymorphism

      ea0063p177
    • The association of fibroblast growth factor 23 with other factorsof mineral and bone disorder in chronic kidney disease

      ea0063p178
    • Delivery in the diabetic women

      ea0063p179
    • Peripheral arterial disease in Asian Type 2 diabetes mellitus under 65 years old and its risk factors

      ea0063p180
    • Gestational diabetes mellitus and continuous glucose monitoring: glycemic patterns and pregnancy outcomes

      ea0063p181
    • Evaluation of leptin levels in diabetic and nondiabetic patients with increased BMI

      ea0063p182
    • Adiponectin concentrations in type 2 diabetes mellitus patients compared with healthy controls

      ea0063p183
    • Diagnosis of type 1 DM in a patient with Hydroxymethylglutaric aciduria: Case report

      ea0063p184
    • Novel clusters of adult-onset Diabetes: Casuistic from an Endocrinology Department

      ea0063p185
    • Relationship between cortisoluria and the presence of metabolic syndrome among HIV-infected patients

      ea0063p186
    • Complication of bariatric surgery as a reason of unsuccessful hypothyroidism and hypoparathyrosis treatment

      ea0063p187
    • Assessment of asymptomatic coronary aretry disease using myocardial perfusion scan in diabetic patients

      ea0063p188
    • HbA1c as a marker of glycemic control in patients with thalessemia HbH disease

      ea0063p189
    • HbA1C as a marker of retrograde glycemic control in diabetes patient with co-existed beta thalassemia: Case report

      ea0063p190
    • Clinical determinants of mean platelet volume in patients with abdominal obesity from different age groups

      ea0063p191
    • Large phenotypic variability of diabetes due to ABCC8 gene mutation illustrated by the paradigm of a family

      ea0063p192
    • Find prevalence of type 2 diabetes mellitus (DM) in age, BMI, symptoms and comorbidities (hypertension, dyslipidimia) in Indian scenario

      ea0063p193
    • Clinical case of insulin autoimmune syndrome

      ea0063p194
    • Evaluation of distance learning activities for healthcare professionals in diabetes management in Albania

      ea0063p195
    • Type 1 diabetic patients with more than five years of disease have increased global methylation levels

      ea0063p196
    • Results of application intensive weight management program in overweight (obese) patients with type 2 diabetes in real clinical practice

      ea0063p197
    • Structural changes of bone tissue in patients with type 1 diabetes mellitus

      ea0063p198
    • Early morphofunctional changes in the myocardium in young people with type 1 diabetes can be detected by magnetic resonance imaging

      ea0063p199
    • PCSK9 inhibitors effects after 2 years in real life

      ea0063p200
    • Acquired generalized lipodystrophy: a new cause of Anti-PD-1 immune-related diabetes

      ea0063p201
    • Necrotizing external otitis: a severe form of otitis in diabetic patients

      ea0063p202
    • Does osteocalcin have a role in Turkish gestational diabetes mellitus and its subgroups

      ea0063p203
    • False memory is very common by elderly diabetics and could be a big problem in patients education and diabetes outcome

      ea0063p204
    • GLP-1 secretion after oral glucose load is greater as eGFR is lower

      ea0063p205
    • Lessons from studying the characteristics of type 1 diabetes mellitus patients in a tertiary hospital in Singapore

      ea0063p206
    • An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany

      ea0063p207
    • Lipoprotein apheresis during pregnancy in severe familial hypercholesterolemia - How and when should we switch treatment in the era of PCSK9 monoclonal antibodies?

      ea0063p208
    • Insulin sensitivity and counter regulatory responses following hypoglycemia in healthy and type 1 diabetes patients

      ea0063p209
    • Cardiovascular complications in metabolic syndrome in the Chernobyl NPP accident clean-up workers of in a late period upon exposure to ionizing radiation

      ea0063p210
    • Pattern of C-peptide response to oral glucose tolerance test: interest and reference values

      ea0063p211
    • Microalbuminuria and its relation to other factors of cardiovascular risk in type 2 diabetic patients

      ea0063p212
    • Pecularites of psychoemotional state at diabetes mellitus

      ea0063p213
    • Peroxisome proliferator activated receptor gamma mutation responsible for partial lipodystrophy with end stage renal disease: pharmacokinetics of metreleptine during hemodialysis: Clinical case report

      ea0063p214
    • Lipodistrophy, a rare disease: 'If you don't think about it, you doesn't diagnose it'

      ea0063p215
    • Please Don't Sugarcoat it: An avoidable case of Euglycaemic DKA in the setting of a SGLT-2 Inhibitor

      ea0063p216
    • Metabolic health is strongly predicted by free Testosterone and SHBG levels in non-obese postmenopausal women

      ea0063p217
    • The presence of polymorphic variant A1298C of the MTHFR (methylenetetrahydrofolate reductase) gene is associated with lower body mass index in girls with anorexia nervosa

      ea0063p218
    • The inverted U-shaped curvilinear effect of fat mass on bone mineral density in Korean adolescent teenagers

      ea0063p219
    • The effect of dapagliflozin add on to triple combination therapy in Type 2 diabetes

      ea0063p220
    • The correlation between overweight and beta-cell function in a healthy young population: a cross-sectional study in Korea

      ea0063p221
    • Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin: biochemical assessment in a series of 106 patients

      ea0063p222
    • The association between serum cystatin C and carotid artery intima-media thickness in Korean type 2 diabetic patients

      ea0063p223
    • Prevalence of psychiatric comorbidities in diabetic patients who are candidates for therapy with SGLT2 inhibitors: clinical and metabolic characteristics

      ea0063p224
  • Pituitary and Neuroendocrinology 1
  • • Efficacy and safety of multimodal therapy in the management of aggresive prolactinoma

      ea0063p225
    • Metabolic fingerprint of acromegaly and its potential usefulness in clinical practice

      ea0063p226
    • NCKX3 knockout mice showed abnormal motor function and social behavior

      ea0063p227
    • Long terms effects of cranial irradiation for nasopharyngeal carcinoma on hypothalamic-pituitary function - a 5-years longitudinal study

      ea0063p228
    • A rare case of recurrent granulomatous hypophysitis treated with a trial of oral glucocorticoids

      ea0063p229
    • The role of interleukin-1 in the dynamics of exercise-induced copeptin

      ea0063p230
    • Growth hormone deficiency, which etiologies?

      ea0063p231
    • Mammosomatotropic adenoma and acromegaly: about 3 cases

      ea0063p232
    • Silent somatotropic adenoma: about a case

      ea0063p233
    • Posterior pituitary spindle-cell oncocytoma: case presentation and literature review

      ea0063p234
    • No central adrenal insufficiency found in adults with prader-willi syndrome tested by multiple dose metyrapone test

      ea0063p235
    • Serum aryl hydrocarbon receptor-interacting protein (AIP) levels are independent of serum GH levels both at baseline and in dynamic tests of GH stimulation and suppression

      ea0063p236
    • Some risk factors of re-growth of non-functional pituitary adenomas in patients with growth hormone deficiency

      ea0063p237
    • The frequency of growth retardation among children and adolescents from orphanages in Tashkent city

      ea0063p238
    • Supraselar tumor as cause of amaurosis - the unusual suspects-case series

      ea0063p239
    • Pituitary stalk interruption syndrome: an uncommon presentation

      ea0063p240
    • Long-term results of bilateral adrenalectomy in a patient with cyclic Cushing's syndrome

      ea0063p241
    • Pituitary tumors diagnosed in octogenarians - clinical implications

      ea0063p242
    • Papillary thyroid carcinoma in acromegalic patient diagnosed with McCune Albright syndrome (MAS)

      ea0063p243
    • Effects of octreotide on hallmarks of autophagy and on parameters related to cell viability and metabolic activity in rat pituitary tumor cells

      ea0063p244
    • Effects of body mass index and estimated glomerular filtration rate on pituitary function in patients with non-functioning pituitary tumor

      ea0063p245
    • Salivary carcinoma of the pituitary gland: an exceptional localization never described

      ea0063p246
    • MRI follow-up is not useful in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogs (SMSa)

      ea0063p247
    • Study of relationship between levels of kisspeptin and neurokinin B and markers of calcium-phosphate metabolism and water-electrolyte balance in patients with neuroendocrine disorders

      ea0063p248
    • Spontaneous pregnancy obtained in persistent Cushing Disease treated with Cabergoline: Report of two cases

      ea0063p249
    • Genetic study of AHR exonic part and GNAS intronic part mutations in some of Iraqi acromegalic patients

      ea0063p250
    • Primary infundibulohypophysitis in a young man with DI and Hypogonadism

      ea0063p251
    • A case of 'micromegaly': need for revision of oral glucose tolerance test (OGTT) cut-offs with modern growth hormone assays in acromegaly

      ea0063p252
    • What patients with acromegaly have to say about their diagnostic pathway: A qualitative study

      ea0063p253
    • IgG4-releated hypophysitis: A case report

      ea0063p254
    • Trunk fat increase is prevented both in patients undergoing long-lasting continuous r-hGH therapy and in those who discontinued r-hGH compared to untreated patients: results from baseline data of the MAGHD study

      ea0063p255
    • Hyperglycemia and pasireotide lar in acromegaly: a study with continuous glucose monitoring

      ea0063p256
    • Radiation therapy in patients with pituitary somatotropinomas

      ea0063p257
    • Anterior pituitary insufficiency in clinically non-functioning pituitary microadenoma

      ea0063p258
    • Neural network for predicting recurrence of the Cushing's disease within three years after neurosurgical treatment

      ea0063p259
    • Hyperglycemia in patients with acromegaly treated with pasireotide LAR

      ea0063p260
    • Novel insight into ACTH-secreting pituitary tumors biological behavior: somatostatin receptor type 5 (SST5) modulation by ubiquitin specific peptidase 8 (USP8)

      ea0063p261
    • Rare lesions of sellar, parasellar and suprasellar pathologies

      ea0063p262
    • Baseline characteristics of adult patients with growth hormone deficiency (GHD) enrolled in NordiNet® International Outcome Study (IOS): are there variations between countries?

      ea0063p263
    • [beta]-arrestin 2 expression is required for dopamine receptor type 2 (DRD2) inhibitory effects on Akt phosphorylation and cell proliferation in PRL-secreting and non functioning pituitary tumors

      ea0063p264
    • Somatostatin receptor type 2 trafficking through the cytoskeleton: role of scaffolding proteins Filamin A and [beta]-arrestin 2

      ea0063p265
    • Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH and GH-secreting pituitary adenoma cell lines

      ea0063p266
    • Somatostatin receptor type 5 modulation by Filamin A in ACTH-secreting pituitary tumors

      ea0063p267
    • The PATRO adults study of Omnitrope® for the treatment of adult patients with growth hormone deficiency: latest safety results

      ea0063p268
    • Diabetes insipidus and diabetes mellitus type 2 diagnosed at the same time in a male with langerhans cell histiocytosis

      ea0063p269
    • Assessment of endocrine function before and after transsphenoidal surgery for Cushing s disease

      ea0063p270
    • Diverticular perforation of colon: a dangerous complication in Cushing's disease

      ea0063p271
    • A retrospective study of 275 cases of pituitary intervention in south great plain region of Hungary

      ea0063p272
    • Differences of efficiency of treatment of isolated growth hormone deficiency and panhypopituitarism in children in real clinical practice

      ea0063p273
    • Functioning gonadotroph adenoma in a 46 years old male

      ea0063p274
    • Acromegaly: ominous cause of hirsutism

      ea0063p275
    • Pituitary apoplexy: clinical features, management and outcomes

      ea0063p276
    • Gross total versus incomplete resection of craniopharyngioma in adults

      ea0063p277
    • When a rare syndrome keeps behaving in rarer manners over and over again!

      ea0063p278
    • Ipilumumab induced hypophysitis

      ea0063p279
    • Acute lethargy, the main symptom of macroprolactinoma

      ea0063p280
    • Pituitary apoplexy: which treatment?

      ea0063p281
    • Cushing disease: Clinical presentation

      ea0063p282
    • The Importance of AGR2 Expression in Pituitary Adenoma Tissue Specimens on Tumor Aggressivity

      ea0063p283
    • The assessment of octreotide suppression test, ihc- and mr-structure, mr-signal of gh-producing pituitary adenoma for determining the prognosis of disease and management.

      ea0063p284
    • Precocious puberty in girls in Qazvin, Iran from 2006-2018

      ea0063p285
    • Spinal Epidural Lipomatosis: A rare complication of Cushing's disease

      ea0063p286
    • Diagnostic tests in Cushing's disease

      ea0063p287
    • Efficacy and safety of dopamine agonists in psychiatric patients treated with antipsychotics and presenting a macroprolactinoma

      ea0063p288
    • Imaging features of children with growth hormone deficiency

      ea0063p289
    • The polyuria-polydipsia syndrome: clinical and etiological profiles

      ea0063p290
    • Syndromic growth retardation: etiological aspects

      ea0063p291
    • GH deficiency and congenital malformation of the hypothalamic-pituitary axis: experience of the Endocrinology-diabetology Department of the Mohammed VI University Hospital Center of Oujda, Morocco

      ea0063p292
    • Long-term effects of GH replacement therapy on thyroid function in children with GH deficiency

      ea0063p293
    • Menstrual dysfunction (MD) with ACTH dependent Cushing syndrome

      ea0063p294
    • Silent, isolated ACTH-deficiency in melanoma patients treated with immune checkpoint inhibitors

      ea0063p295
    • A Case of Granulomatous Hypophysitis Mimicking Pituitary Macroadenoma

      ea0063p296
  • Reproductive Endocrinology 1
  • • The natural course of normal weight women with polycystic ovary syndrome: an insight into metabolic changes of a large Caucasian cohort

      ea0063p297
    • Inhibin-B and FSH are the best predictors of spermatogenesis

      ea0063p298
    • High prevalence of psychopathologies among transgender patients presenting at a large tertiary center: implication for the treating clinicians

      ea0063p299
    • Bardet-Biedl syndrome in two siblings: a rare entity

      ea0063p300
    • After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)

      ea0063p301
    • Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: Study during up to 11 years on hypogonadic patients. (January 2019)

      ea0063p302
    • Evidence for preserved ovarian reserve in transgender men receiving testosterone therapy: Anti-mullerian hormone serum levels decrease modestly after one year of treatment

      ea0063p303
    • Female infertility: etiological factors and management

      ea0063p304
    • Assessement of frequency of depression in women of reproductive age with polycystic ovarian syndrome

      ea0063p305
    • A rare cause of the hypergonadotropic hypogonadism: GAPO sydrome

      ea0063p306
    • Menstrual disorders in patients with different etiology of hyperprolactinemia

      ea0063p307
    • Reproductive phenotype in 265 men with congenital hypogonadotropic hypogonadism and 531 men with acquired hypogonadotropic hypogonadism: a monocentric comparative study

      ea0063p308
    • Ano-genital distance in children born of mothers with polycystic ovary syndrome - Odense Child Cohort

      ea0063p309
    • Diagnosis and management of severe hyperandrogenism in the context of tumoral suspicion: case-series report from a tertiary hospital

      ea0063p310
    • Ovarian reserve and exposure to environmental pollutants (ORExPo study)

      ea0063p311
    • Normosmic hypogonadotropic hypogonadism associated with a novel TACR3 mutation

      ea0063p312
    • A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants

      ea0063p313
    • Azoospermia revealing the uncommon Jacob's syndrome

      ea0063p314
    • Pituitary tumor as a cause of male infertility

      ea0063p315
    • The differences in steroid hormones levels in the peripartum period caused by fetal sex and delivery type

      ea0063p316
    • Characterization of the expression and physiological roles of thyroid-stimulating hormone receptor in the male testis

      ea0063p317
    • Semen quality in uncontrolled acromegalic patients with hypogonadism

      ea0063p318
    • Characteristics, geographical distribution and age at diagnosis of patients with Klinefelter syndrome in Italy: a cohort study from the Klinefelter Italian Group (KING)

      ea0063p319
    • Gonadal Function in Human Immunodeficiency Virus (HIV)-Infected Men: comparison between Isotopic Dilution-Liquid Chromatography-Tandem Mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay (CI)

      ea0063p320
    • Automated free testosterone assay: validation and usual values

      ea0063p321
    • Assessment of biochemical hyperandrogenism in PCOs by liquid chromatography tandem mass spectrometry using a multisteroid kit: focus on testosterone and androstenedione

      ea0063p322
    • Effects of fludioxonil on cardiac differentiation of mouse embryonic stem cells

      ea0063p323
    • Monitoring testosterone gel administration: timing and dosage

      ea0063p324
    • Menstrual cycle characteristics in women with premature ovarian insufficiency

      ea0063p325
    • Endocrine and menstrual disorders in adolescent girls: clinical parallels

      ea0063p326
    • Effects of percutaneous treatment of left varicocele on spermatogenetic and endocrine function of the testis: results from a 12-month follow-up

      ea0063p327
    • Predictive factors of polycystic ovary syndrome in women with morbid obesity

      ea0063p328
    • Randomised Controlled Trials in women with polycystic ovary syndrome do not represent the majority of patients who are in a primary care setting: systematic review and meta-analysis

      ea0063p329
    • The awareness of the side effects of the use of AAS as a factor of the conscious rejection of their use: The price of a beautiful body

      ea0063p330
    • Fenhexamid increased the cell viability and metastasis of breast cancer cells via an estrogen receptor-dependent and PI3K/AKT pathway

      ea0063p331
    • Natural estradiol in combined oral contraceptive has a favorable inflammation and lipid profile compared with preparation containing ethinyl estradiol- a randomized controlled trial

      ea0063p332
    • Modes and actions of inter-individual transfer of estradiol and progesterone among conspecifics in both mice and bats

      ea0063p333
    • Definition of hormonal cut-off values for discriminating polycystic ovary syndrome from non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0063p334
    • Lipid parameters during pregnancy

      ea0063p335
    • Dysmenorrhea prevalence and its impact on daily functioning of university nursing students in greece

      ea0063p336
  • Thyroid 1
  • • The serum thyroglobulin level after discontinuation of two weeks of thyroid hormone in patients with differentiated thyroid cancer can be used to determine the therapeutic dose of radioiodine

      ea0063p337
    • Thyroid-associated orbitopathy and quality of life: correlation of GO-QoL with clinical activity score and severity in 101 patients

      ea0063p338
    • The influence of thyroid gland subclinical form on hypercholesterolemia patients in Latvia

      ea0063p339
    • Endocrinopathies post Immune check point inhibitors

      ea0063p340
    • Hashimotos encephalopathy in Graves' disease

      ea0063p341
    • Role of lipid peroxidation in the progression of autoimmune thyroiditis

      ea0063p342
    • Clinical evaluation of TSH-receptor antibody measured by a third generation fully automated electrochemiluminescence immunoassay method in Turkish patients with Graves' disease

      ea0063p343
    • Association between hypothyroidism and venous thromboembolism and the effect of levothyroxine in the adult: a nationwide Cohort study

      ea0063p344
    • Should narrower TSH and free thyroid hormone levels be targeted to reduce the cardiovascular risk of euthyroid subjects?

      ea0063p345
    • Thyroid dysfunction in Egyptian HCV patients: prevalence and possible triggering factors

      ea0063p346
    • Management of refractory hypothyroidism with intramuscular levothyroxine: a clinical case

      ea0063p347
    • Thyroid angiosarcoma: in the light of a case

      ea0063p348
    • Collision tumor: A case report of tall cell variant of papillary thyroid carcinoma and laryngeal squamous cell carcinoma

      ea0063p349
    • Outcomes of surgery and radioiodine treatment for neck recurrence in papillary thyroid cancer

      ea0063p350
    • Anaplastic thyroid carcinoma or radiation-induced sarcoma: About a case

      ea0063p351
    • The relationship between thyroid receptor antibody and anti mullerian hormone in Graves' disease

      ea0063p352
    • Infrared thermography in association with indirect calorimetry: a new methodology for diagnosis and follow-up of subclinical hypothyroidism

      ea0063p353
    • How much the implementation of an expert surgical team can improve the incidence of postoperative hypoparathyroidism

      ea0063p354
    • An ununsual thyroid cause for Pyrexia of unknown origin (PUO)

      ea0063p355
    • Relationship among T- and B-lymphocytes of the peripheral blood and thyroid tissue in patients with Graves' disease

      ea0063p356
    • Association between vitamin D receptor gene polymorphisms and Graves' disease: a systematic review and meta-analysis

      ea0063p357
    • Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis: diagnostic and therapeutic modalities

      ea0063p358
    • A rare cause of goiter

      ea0063p359
    • Changing practice in the management of differentiated thyroid carcinoma - experience at Brugmann Hospital in Brussels

      ea0063p360
    • Intraoperative Neuromonitoring of the laryngeal nerves in thyroid surgery

      ea0063p361
    • Weekly dose of L-thyroxine as a first line treatment for hypothyroidism in young and middle aged working females

      ea0063p362
    • Analysis of clinical and biological predictors of malignancy in thyroid nodules

      ea0063p363
    • Sensitivity and specificity of ultrasound features in predicting malignant thyroid nodules

      ea0063p364
    • Comparison of G-CSF and non-G-CSF treatment of agranulocytosis in patients with hyperthyroidism: a meta-analysis

      ea0063p365
    • Ocular cavity metastasis from poorly differentiated thyroid carcinoma

      ea0063p366
    • Giant cystic pheochromocytoma: A clinically silent entity

      ea0063p367
    • Glucocorticoid Functional Reserve in Hashimoto Hypothyroidism before and after LT4 replacement

      ea0063p368
    • Impact of thyroid autoimmunity on obstetric and perinatal outcomes in pregnant women with subclinical hypothyroidism

      ea0063p369
    • Abstract unavailable

      ea0063p370
    • Navigating thyroid storm: The role of plasmapheresis in a patient also needing urgent aortic valve replacement surgery

      ea0063p371
    • Prognostic factors for lymph node metastases in patients with papillary thyroid microcarcinoma

      ea0063p372
    • Histological characteristics in thyroid carcinoma: our experience in the last fifteen years

      ea0063p373
    • Impact of total thyroidectomy on quality of life: the prospective ThyrQoL multicenter trial

      ea0063p374
    • Can urinary iodine be used in the diagnosis and follow up of subacute thyroiditis?

      ea0063p375
    • Comparative analysis of Hashimoto's and Riedel's thyroiditis morphology and immunohistochemistry

      ea0063p376
    • Is total thyroidectomy and bilateral central lymph node dissection essential for patients with unilateral cN1a papillary thyroid carcinoma?

      ea0063p377
    • Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?

      ea0063p378
    • Iodine status of schoolchildren of Belarus in 2017-2018

      ea0063p379
    • The Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment

      ea0063p380
    • Switch from tablet to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia in thyroxine-replaced postmenopausal women under simultaneous calcium supplementation.